Prenatal Care Practice Questions

Q: Folic acid is typically recommended during which trimester of pregnancy?

First. **Explanation:** **Why the First Trimester is Correct:** Folic acid (Vitamin B9) is critical during the **first trimester**, specifically during the first 28 days of gestation, because this is the period of **organogenesis** and **neural tube closure**. The neural tube closes by the 28th day after conception—often before a woman realizes she is pregnant. Adequate folate levels are essential for DNA synthesis and amino acid metabolism; a deficiency leads to **Neural Tube Defects (NTDs)** such as spina bifida and anencephaly. To be most effective, supplementation should ideally begin **pre-conceptionally** (at least 1 month prior) and continue through the first 12 weeks of pregnancy. **Why Other Options are Incorrect:** * **Second and Third Trimesters:** While folic acid is often continued as part of Iron-Folic Acid (IFA) tablets to prevent maternal megaloblastic anemia, its primary role in preventing structural congenital malformations (NTDs) is over by the end of the first trimester. * **Throughout Pregnancy:** While not harmful, the "typical" recommendation specifically targeting the prevention of NTDs focuses on the peri-conceptional period and the first trimester. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Dose:** 400 mcg (0.4 mg) daily for low-risk pregnancies. * **High-Risk Dose:** 4 mg (4000 mcg) daily if there is a previous history of a child with NTD, maternal diabetes, or use of anti-epileptic drugs (e.g., Valproate). * **IFA Prophylaxis (Government of India/Anemia Mukt Bharat):** 100 mg elemental iron + 500 mcg folic acid daily for 180 days, starting from the second trimester (14 weeks). * **Megaloblastic Anemia:** Folic acid deficiency is the most common cause of megaloblastic anemia in pregnancy.

Q: Alpha-fetoprotein (AFP) levels are associated with various clinical aspects in obstetrics. All of the following conditions are associated with high maternal serum AFP levels, EXCEPT:

Down syndrome (Trisomy 21). **Explanation:** Maternal Serum Alpha-Fetoprotein (MSAFP) is a glycoprotein produced initially by the yolk sac and later by the fetal liver. It peaks in maternal circulation between 16–18 weeks of gestation. Understanding the direction of AFP levels is crucial for prenatal screening. **Why Down Syndrome is the Correct Answer:** In pregnancies affected by **Down syndrome (Trisomy 21)**, MSAFP levels are characteristically **decreased** (usually <0.5 MoM). This is often accompanied by low unconjugated estriol (uE3) and elevated levels of Beta-hCG and Inhibin-A (the "Quadruple Test" pattern). **Analysis of Incorrect Options (Conditions with High AFP):** * **Multiple Pregnancy:** More than one fetus results in a higher cumulative production of AFP, leading to elevated maternal serum levels. * **Intrauterine Fetal Demise (IUFD):** Fetal death leads to the breakdown of fetal tissues and skin barriers, causing a massive leak of AFP into the amniotic fluid and subsequently into the maternal circulation. * **Congenital Renal Anomalies:** Conditions like Finnish-type nephrosis or posterior urethral valves cause excessive protein (AFP) to be excreted via fetal urine into the amniotic fluid, raising maternal levels. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of elevated MSAFP:** Underestimation of gestational age (wrong dates). * **Highest elevation of AFP:** Seen in **Anencephaly** and Open Neural Tube Defects (ONTD) due to direct exposure of fetal vessels/tissues. * **Low AFP levels:** Associated with Trisomy 21, Trisomy 18 (Edwards syndrome), Molar pregnancy, and Maternal Obesity. * **Abdominal Wall Defects:** Both Omphalocele and Gastroschisis cause high AFP, but levels are typically higher in Gastroschisis.

Q: At what gestational age can ultrasound detect cardiac activity?

5-6 weeks. **Explanation:** In early pregnancy, the detection of cardiac activity is a critical milestone for confirming a viable intrauterine pregnancy. On a high-resolution **Transvaginal Ultrasound (TVS)**, the fetal heart pole and cardiac flickering can typically be visualized when the embryo reaches a crown-rump length (CRL) of **2–4 mm**, which corresponds to a gestational age of **5.5 to 6 weeks**. * **Option A (5-6 weeks):** This is the correct window. By the end of the 5th week, the primitive heart tube begins to beat. TVS can reliably detect this activity between 5.5 and 6 weeks. * **Option B & C (6-8 weeks):** While cardiac activity is certainly visible during this time, these options are "late." By 6.5 to 7 weeks, cardiac activity should be visible even on Transabdominal Ultrasound (TAS). * **Option D (8-10 weeks):** This is well beyond the initial detection period. By this stage, the embryo has developed into a fetus with clearly identifiable limbs and movement. **High-Yield Clinical Pearls for NEET-PG:** 1. **Discriminatory Milestones (TVS):** * **Gestational Sac:** 4.5–5 weeks. * **Yolk Sac:** 5–5.5 weeks (First intragestational structure seen). * **Cardiac Activity:** 5.5–6 weeks. 2. **The "Rule of 10":** If using **Transabdominal Ultrasound (TAS)**, milestones are generally delayed by about 1 week compared to TVS. 3. **Diagnosis of Pregnancy Failure:** According to the SRU criteria, pregnancy is considered non-viable if there is a **CRL ≥ 7 mm** with no cardiac activity on TVS. 4. **Heart Rate:** In early pregnancy (6 weeks), the normal fetal heart rate is approximately 100–115 bpm, increasing to 140–170 bpm by 9 weeks.

Q: A 35-year-old female with a previous history of a child with Down's syndrome presents with 18 weeks of amenorrhea. What is the investigation of choice to rule out Down's syndrome in the present pregnancy?

Amniocentesis. **Explanation:** The patient is currently at **18 weeks of gestation** and has a high-risk history (previous child with Down’s syndrome). To "rule out" a chromosomal anomaly, a **diagnostic test** (karyotyping) is required rather than a screening test. **1. Why Amniocentesis is the Correct Answer:** Amniocentesis is the gold-standard diagnostic procedure performed between **15–20 weeks** of gestation. Since the patient is at 18 weeks, this is the most appropriate window. It involves aspirating amniotic fluid to obtain fetal desquamated cells for karyotyping, providing a definitive diagnosis of trisomy 21. **2. Why the other options are incorrect:** * **Triple Test (Option A):** This is a **screening test** (measuring AFP, hCG, and uE3). Screening tests only provide a risk probability and cannot "rule out" or confirm the diagnosis. * **Chorionic Villous Biopsy (CVS) (Option D):** While CVS is a diagnostic test, it is ideally performed between **10–13 weeks**. At 18 weeks, the placenta is more formed, and amniocentesis is technically safer and preferred over CVS. * **Cordocentesis (Option C):** Also known as Percutaneous Umbilical Blood Sampling (PUBS), it is usually performed after **18–20 weeks**. However, it carries a higher risk of fetal loss (1–2%) compared to amniocentesis (0.5%) and is generally reserved for rapid karyotyping or fetal blood disorders. **Clinical Pearls for NEET-PG:** * **Best time for Amniocentesis:** 15–20 weeks (Early amniocentesis <14 weeks is avoided due to risk of clubfoot/talipes). * **Most common complication of Amniocentesis:** Premature rupture of membranes (PROM) and fetal loss (0.5%). * **Combined Screening (1st Trimester):** Nuchal translucency (NT) + PAPP-A + hCG (performed at 11–13+6 weeks). * **Quadruple Test:** Triple test + Inhibin A (best screening sensitivity in the 2nd trimester).

Q: Screening for gestational diabetes mellitus (GDM) is not required for which of the following conditions?

Previous pre-eclampsia. **Explanation:** The screening for Gestational Diabetes Mellitus (GDM) is primarily targeted at identifying women with specific risk factors that suggest underlying insulin resistance or metabolic dysfunction. **Why Option D is correct:** While **Pre-eclampsia** is a *complication* of GDM, a history of pre-eclampsia in a previous pregnancy is not a standalone indication for GDM screening in the current pregnancy according to standard guidelines (like DIPSI or IADPSG). Pre-eclampsia is primarily a vascular and endothelial disorder. While it shares some metabolic risk factors with GDM (like obesity), it does not directly imply a high risk of glucose intolerance in the same way that fetal macrosomia or unexplained fetal loss does. **Why the other options are wrong:** * **A. Previous macrosomic infant (>4kg):** This is a classic hallmark of fetal hyperinsulinemia caused by maternal hyperglycemia. It indicates a high risk of recurrent GDM. * **B. Previous congenital malformation:** Poorly controlled pre-gestational or early gestational diabetes is teratogenic (e.g., Sacral agenesis, Cardiac defects). A history of malformation necessitates early screening to rule out undiagnosed Type 2 DM. * **C. Previous stillbirth:** Unexplained third-trimester stillbirth is a known complication of maternal hyperglycemia due to fetal acidemia and hypoxia. **High-Yield Clinical Pearls for NEET-PG:** * **DIPSI Guidelines (India):** Screening is performed at the first prenatal visit and repeated at 24–28 weeks. A single-step test using **75g glucose** is used; a 2-hour plasma glucose **≥140 mg/dL** is diagnostic of GDM, regardless of the fasting state. * **Risk Factors for GDM:** BMI >30 kg/m², Age >35, First-degree relative with DM, PCOS, and history of GDM in a previous pregnancy. * **Most common malformation in GDM:** Ventricular Septal Defect (VSD). * **Most specific malformation in GDM:** Caudal Regression Syndrome (Sacral Agenesis).

Q: Anti-D immune globulin is administered to Rh-negative women antenatally at which gestational week?

28 weeks. **Explanation:** The administration of Anti-D immune globulin (RhoGAM) is a critical preventive measure against Rh isoimmunization in Rh-negative, unsensitized mothers. **Why 28 weeks is correct:** The primary goal of antenatal prophylaxis is to neutralize any fetal Rh-positive red blood cells that may enter the maternal circulation. While the risk of fetomaternal hemorrhage (FMH) is low in the first two trimesters, it increases significantly in the third trimester as the placenta thins. Research shows that the incidence of "silent" sensitization peaks after 28 weeks. Administering Anti-D at **28 weeks** provides protective antibody levels that last for approximately 12 weeks, covering the remainder of the pregnancy until delivery. **Analysis of Incorrect Options:** * **A & B (20 & 24 weeks):** At these stages, the risk of spontaneous FMH is negligible. Administering Anti-D this early would result in sub-therapeutic antibody levels by the time the mother reaches full term, leaving her vulnerable during the period of highest risk. * **D (30 weeks):** While closer to the window, waiting until 30 weeks leaves a two-week "gap" (28–30 weeks) where sensitization could occur. International guidelines (ACOG/RCOG) have standardized 28 weeks to maximize the duration of protection. **High-Yield Clinical Pearls for NEET-PG:** 1. **Standard Dose:** 300 mcg (1500 IU) is the standard dose given at 28 weeks; it covers up to 30 ml of fetal whole blood (or 15 ml of fetal RBCs). 2. **Postpartum Dose:** A second dose must be given within **72 hours of delivery** if the neonate is confirmed Rh-positive. 3. **Indirect Coombs Test (ICT):** Anti-D is only given if the mother is **ICT negative** (unsensitized). If ICT is positive, the mother is already sensitized, and Anti-D is of no use. 4. **First Trimester Events:** For abortions or ectopic pregnancies (<13 weeks), a smaller dose of 50 mcg is typically sufficient.

Q: A healthy 20-year-old G1P0 presents for her first OB visit at 10 weeks gestational age. She denies any significant medical history both personally and in her family. Which of the following tests should NOT be ordered as part of the initial prenatal care visit?

One-hour glucose tolerance test. **Explanation:** The initial prenatal visit (booking visit) aims to establish a baseline for maternal health and screen for conditions that could adversely affect the pregnancy. **Why Option C is correct:** The **One-hour Glucose Tolerance Test (GTT)** is a screening tool for Gestational Diabetes Mellitus (GDM). In a low-risk, healthy patient (G1P0, no family history, normal BMI), GDM screening is standardly performed between **24 and 28 weeks** of gestation. This timing is chosen because insulin resistance, driven by placental hormones like Human Placental Lactogen (hPL), peaks during the late second and early third trimesters. Performing it at 10 weeks in a low-risk patient is premature. **Why the other options are incorrect:** * **HIV (Option A):** Universal "opt-out" screening for HIV is mandatory at the first visit to prevent vertical transmission through early antiretroviral therapy. * **Hepatitis B surface antigen (HBsAg) (Option B):** Screening is essential at the first visit to identify neonates who will require the Hep B vaccine and Immunoglobulin (HBIG) at birth. * **Type and Screen (Option D):** Determining blood group and Rh status is critical to identify Rh-negative mothers who require Anti-D prophylaxis to prevent isoimmunization. **Clinical Pearls for NEET-PG:** * **Early GDM Screening:** Only indicated at the first visit if the patient is high-risk (BMI >30, history of GDM, known PCOS, or strong family history of Type 2 DM). * **DIPSI Guidelines:** In India, the Diabetes in Pregnancy Study Group India (DIPSI) recommends a 75g Oral Glucose Tolerance Test (OGTT) at the first visit regardless of risk, but international guidelines (ACOG/RCOG) and standard textbooks (Williams) follow the 24-28 week window for low-risk patients. * **Other Initial Tests:** CBC (for anemia), Syphilis (VDRL/RPR), Rubella immunity, and Urine culture (for asymptomatic bacteriuria).

Question 1

A health-conscious vegetarian patient regularly ingests mega doses of vitamins and herbal therapies daily. She is planning pregnancy and seeks advice on diet and nutrition. Which of the following statements regarding diet recommendations in pregnancy is true?

Accepted Answer

During pregnancy, the majority of consumed protein should be supplied from animal sources.

Answer

Herbal medications are natural, so there is no reason to avoid these dietary supplements during pregnancy.

Answer

Routine supplementation of vitamin A is necessary during pregnancy as dietary intake alone is insufficient.

Answer

During pregnancy, vegetarians obtain sufficient vitamin B12 in their diet for the fetus.

Question 2

Folic acid is typically recommended during which trimester of pregnancy?

Accepted Answer

First

Answer

Second

Answer

Third

Answer

Throughout pregnancy

Question 3

Alpha-fetoprotein (AFP) levels are associated with various clinical aspects in obstetrics. All of the following conditions are associated with high maternal serum AFP levels, EXCEPT:

Accepted Answer

Down syndrome (Trisomy 21)

Answer

Multiple pregnancy

Answer

Intrauterine fetal demise (IUFD)

Answer

Congenital renal anomalies

Question 4

A 21-year-old female presents with amenorrhea of 5 weeks. Her urine pregnancy test is positive. Ultrasound shows a gestational sac and yolk sac within the uterus. No fetal pole or cardiac activity is visible. Crown-rump length (CRL) is 8 mm and mean sac diameter (MSD) is 28 mm. What is the next best step?

Accepted Answer

High probability of nonviable pregnancy; repeat scan after 7 days to confirm.

Answer

Advise medical termination of pregnancy as it is a nonviable pregnancy.

Answer

Consider ectopic pregnancy; administer methotrexate.

Answer

High probability of viable pregnancy; repeat scan after 7 days.

Question 5

At what gestational age can ultrasound detect cardiac activity?

Accepted Answer

5-6 weeks

Answer

6-7 weeks

Answer

7-8 weeks

Answer

8-10 weeks

Question 6

A 35-year-old female with a previous history of a child with Down's syndrome presents with 18 weeks of amenorrhea. What is the investigation of choice to rule out Down's syndrome in the present pregnancy?

Accepted Answer

Amniocentesis

Answer

Triple test

Answer

Cordocentesis

Answer

Chorionic villous biopsy

Question 7

Screening for gestational diabetes mellitus (GDM) is not required for which of the following conditions?

Accepted Answer

Previous pre-eclampsia

Answer

Previous delivery of a macrosomic infant

Answer

Previous delivery with congenital malformation

Answer

Previous stillbirth

Question 8

A 36-year-old HIV-positive female is on antiretroviral therapy. Which of the following first-trimester markers of Down syndrome would be affected?

Accepted Answer

Beta-hCG

Answer

PAPP-A

Answer

Nuchal Translucency (NT)

Answer

All of the above

Question 9

Anti-D immune globulin is administered to Rh-negative women antenatally at which gestational week?

Accepted Answer

28 weeks

Answer

20 weeks

Answer

24 weeks

Answer

30 weeks

Question 10

A healthy 20-year-old G1P0 presents for her first OB visit at 10 weeks gestational age. She denies any significant medical history both personally and in her family. Which of the following tests should NOT be ordered as part of the initial prenatal care visit?

Accepted Answer

One-hour glucose tolerance test

Answer

HIV

Answer

Hepatitis B surface antigen

Answer

Type and screen

Prenatal Care — MCQs

Prenatal Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?